Novartis Changes Direct-to-Consumer Ads for Kisqali

Novartis was forced to change some of the claims it was making in its direct-to consumer advertising about the breast cancer drug Kisqali (ribociclib) after a challenge from Lilly.
Medscape Medical News

source https://www.medscape.com/viewarticle/987533?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?